药物发现资讯学市场－全球产业规模、份额、趋势、机会和预测，依模式、工作流程、服务、最终用户、地区和竞争格局划分，2020-2030年预测

2024年全球药物发现资讯学市场规模为34.8亿美元，预计2030年将以9.40%的复合年增长率成长至59.7亿美元。药物发现资讯学是指应用计算方法和分析工具来管理、分析和解读药物发现过程中产生的大量且多样化的资料，从而提高识别和优化潜在候选药物的效率。该市场的成长主要受以下因素驱动：对药物研发的大量投资、处理日益增长且复杂的科学资料的必要性，以及缩短药物研发週期和降低相关成本的持续压力。

主要市场驱动因素

主要市场挑战

主要市场趋势

目录

第一章：产品概述

第二章：研究方法

第三章：执行概要

第四章：顾客之声

第五章：全球药物发现资讯学市场展望

• 市场规模及预测
  • 按价值
• 市占率及预测
  • 按模式（内部开发、外包）
  • 按工作流程（探索、开发）
  • 依服务分类（序列分析平台、分子建模、分子对接、临床试验资料管理、其他）
  • 按最终用户（製药和生物技术公司、合约研究组织 (CRO)、其他）
  • 按地区
  • 按公司（2024 年）
• 市场地图

第六章：北美药物发现资讯学市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 美国
  • 加拿大
  • 墨西哥

第七章：欧洲药物发现资讯学市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区药物发现资讯学市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲药物发现资讯学市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿联酋
  • 南非

第十章：南美药物发现资讯学市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章：市场动态

• 司机
• 挑战

第十二章：市场趋势与发展

• 併购（如有）
• 产品发布（如有）
• 最新进展

第十三章：全球药物发现资讯学市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商议价能力
• 顾客的力量
• 替代产品的威胁

第十五章：竞争格局

• Dassault Systemes SE
• IBM Corporation
• Infosys Ltd.
• Schrodinger Inc.
• Jubilant Life Sciences NV
• Aragen Lifescience Ltd.
• Charles River Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Clarivate Analytics LLC
• PerkinElmer Inc.

第十六章：策略建议

第17章调查会社について・免责事项

The Global Drug Discovery Informatics Market, valued at USD 3.48 Billion in 2024, is projected to experience a CAGR of 9.40% to reach USD 5.97 Billion by 2030. Drug discovery informatics involves the application of computational methods and analytical tools to manage, analyze, and interpret the extensive and varied data generated throughout the drug discovery process, thereby enhancing the efficiency of identifying and optimizing potential drug candidates. The market's growth is primarily driven by substantial investments in pharmaceutical research and development, a necessity to process the increasing volume and complexity of scientific data, and the continuous pressure to reduce drug development timelines and associated costs.

Key Market Drivers

The rapid proliferation of big data in drug discovery is a core driver accelerating the growth of the informatics market. The escalating volume and complexity of data generated from genomic sequencing, proteomics, and advanced experimental assays require sophisticated computational tools for effective data management, analysis, and interpretation. This expanding data ecosystem is driving strong demand for informatics platforms capable of integrating diverse datasets and transforming them into actionable insights for identifying and prioritising potential drug candidates. Reflecting the scale of this data generation, the report Genomics Market Size, Trends and Tailored Solutions for Personalized Medicine stated that the global genomics market was valued at USD 38.52 billion in 2024, underscoring the magnitude of information being produced and the corresponding need for high-performance informatics solutions to accelerate early-stage drug development.

Key Market Challenges

The complexity of data integration and persistent interoperability challenges across fragmented platforms and heterogeneous data sources pose a significant constraint on the growth of the Global Drug Discovery Informatics Market. The pharmaceutical industry produces vast volumes of diverse data across multiple workflows, including genomics, proteomics, and clinical trials. However, these datasets frequently remain siloed within disconnected systems, creating substantial barriers to standardisation, consolidation, and holistic analysis. This lack of seamless integration limits the ability to establish a unified and comprehensive research view, which is essential for accelerating drug candidate identification and optimisation.

Key Market Trends

The adoption of cloud-native informatics platforms represents a significant trend in the global drug discovery informatics market, moving away from on-premise infrastructure to scalable, accessible cloud-based solutions. This shift provides enhanced flexibility and computational power for managing and analyzing the vast datasets generated in drug discovery. According to a Pistoia Alliance survey published in September 2025, 80% of life sciences labs now utilize cloud data platforms, marking an increase from 70% in 2023. This growth underscores the industry's recognition of cloud benefits, including improved collaboration and reduced IT overheads.

Key Market Players

• Dassault Systemes SE
• IBM Corporation
• Infosys Ltd.
• Schrodinger Inc.
• Jubilant Life Sciences NV
• Aragen Lifescience Ltd.
• Charles River Laboratories Inc.
• Thermo Fisher Scientific Inc.
• Clarivate Analytics LLC
• PerkinElmer Inc.

Report Scope:

In this report, the Global Drug Discovery Informatics Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Drug Discovery Informatics Market, By Mode:

• In-house
• Outsourced

Drug Discovery Informatics Market, By Workflow:

• Discovery
• Development

Drug Discovery Informatics Market, By Services:

• Sequence Analysis Platforms
• Molecular Modelling
• Docking
• Clinical Trial Data Management
• Others

Drug Discovery Informatics Market, By End User:

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROS)
• Others

Drug Discovery Informatics Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Drug Discovery Informatics Market.

Available Customizations:

Global Drug Discovery Informatics Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Drug Discovery Informatics Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Mode (In-house, Outsourced)
  • 5.2.2. By Workflow (Discovery, Development)
  • 5.2.3. By Services (Sequence Analysis Platforms, Molecular Modelling, Docking, Clinical Trial Data Management, Others)
  • 5.2.4. By End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROS), Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2024)
• 5.3. Market Map

6. North America Drug Discovery Informatics Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Mode
  • 6.2.2. By Workflow
  • 6.2.3. By Services
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Drug Discovery Informatics Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Mode
      • 6.3.1.2.2. By Workflow
      • 6.3.1.2.3. By Services
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Drug Discovery Informatics Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Mode
      • 6.3.2.2.2. By Workflow
      • 6.3.2.2.3. By Services
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Drug Discovery Informatics Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Mode
      • 6.3.3.2.2. By Workflow
      • 6.3.3.2.3. By Services
      • 6.3.3.2.4. By End User

7. Europe Drug Discovery Informatics Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Mode
  • 7.2.2. By Workflow
  • 7.2.3. By Services
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Drug Discovery Informatics Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Mode
      • 7.3.1.2.2. By Workflow
      • 7.3.1.2.3. By Services
      • 7.3.1.2.4. By End User
  • 7.3.2. France Drug Discovery Informatics Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Mode
      • 7.3.2.2.2. By Workflow
      • 7.3.2.2.3. By Services
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Drug Discovery Informatics Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Mode
      • 7.3.3.2.2. By Workflow
      • 7.3.3.2.3. By Services
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Drug Discovery Informatics Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Mode
      • 7.3.4.2.2. By Workflow
      • 7.3.4.2.3. By Services
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Drug Discovery Informatics Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Mode
      • 7.3.5.2.2. By Workflow
      • 7.3.5.2.3. By Services
      • 7.3.5.2.4. By End User

8. Asia Pacific Drug Discovery Informatics Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Mode
  • 8.2.2. By Workflow
  • 8.2.3. By Services
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Drug Discovery Informatics Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Mode
      • 8.3.1.2.2. By Workflow
      • 8.3.1.2.3. By Services
      • 8.3.1.2.4. By End User
  • 8.3.2. India Drug Discovery Informatics Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Mode
      • 8.3.2.2.2. By Workflow
      • 8.3.2.2.3. By Services
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Drug Discovery Informatics Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Mode
      • 8.3.3.2.2. By Workflow
      • 8.3.3.2.3. By Services
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Drug Discovery Informatics Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Mode
      • 8.3.4.2.2. By Workflow
      • 8.3.4.2.3. By Services
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Drug Discovery Informatics Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Mode
      • 8.3.5.2.2. By Workflow
      • 8.3.5.2.3. By Services
      • 8.3.5.2.4. By End User

9. Middle East & Africa Drug Discovery Informatics Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Mode
  • 9.2.2. By Workflow
  • 9.2.3. By Services
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Drug Discovery Informatics Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Mode
      • 9.3.1.2.2. By Workflow
      • 9.3.1.2.3. By Services
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Drug Discovery Informatics Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Mode
      • 9.3.2.2.2. By Workflow
      • 9.3.2.2.3. By Services
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Drug Discovery Informatics Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Mode
      • 9.3.3.2.2. By Workflow
      • 9.3.3.2.3. By Services
      • 9.3.3.2.4. By End User

10. South America Drug Discovery Informatics Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Mode
  • 10.2.2. By Workflow
  • 10.2.3. By Services
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Drug Discovery Informatics Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Mode
      • 10.3.1.2.2. By Workflow
      • 10.3.1.2.3. By Services
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Drug Discovery Informatics Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Mode
      • 10.3.2.2.2. By Workflow
      • 10.3.2.2.3. By Services
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Drug Discovery Informatics Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Mode
      • 10.3.3.2.2. By Workflow
      • 10.3.3.2.3. By Services
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Drug Discovery Informatics Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Dassault Systemes SE
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. IBM Corporation
• 15.3. Infosys Ltd.
• 15.4. Schrodinger Inc.
• 15.5. Jubilant Life Sciences NV
• 15.6. Aragen Lifescience Ltd.
• 15.7. Charles River Laboratories Inc.
• 15.8. Thermo Fisher Scientific Inc.
• 15.9. Clarivate Analytics LLC
• 15.10. PerkinElmer Inc.

16. Strategic Recommendations

17. About Us & Disclaimer